| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.666 | 15.355 | 15.619 | 14.411 | 15.084 | 10.089 | 9.651 | 6.296 | 5.883 | 6.534 |
| Total Income - EUR | 13.711 | 15.436 | 15.613 | 14.477 | 18.353 | 10.376 | 9.820 | 6.357 | 6.444 | 6.893 |
| Total Expenses - EUR | 8.657 | 8.003 | 9.079 | 7.576 | 7.352 | 6.377 | 5.633 | 6.127 | 8.384 | 8.764 |
| Gross Profit/Loss - EUR | 5.054 | 7.433 | 6.534 | 6.901 | 11.001 | 3.999 | 4.187 | 231 | -1.941 | -1.871 |
| Net Profit/Loss - EUR | 4.644 | 6.967 | 6.378 | 6.756 | 10.820 | 3.927 | 3.933 | 63 | -1.941 | -1.871 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Perfmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 690 | 173 | 530 | 2.096 | 2.292 | 2.227 | 1.994 | 1.042 | 25.921 | 23.807 |
| Current Assets | 23.192 | 7.305 | 13.158 | 18.562 | 33.095 | 36.261 | 35.141 | 36.289 | 9.425 | 9.430 |
| Inventories | 1.336 | 2.378 | 1.477 | 1.181 | 1.713 | 1.161 | 784 | 444 | 379 | 103 |
| Receivables | 0 | 110 | 79 | 419 | 0 | 0 | 0 | 0 | 110 | 109 |
| Cash | 21.855 | 4.817 | 11.602 | 16.962 | 31.382 | 35.100 | 34.357 | 35.844 | 8.936 | 9.218 |
| Shareholders Funds | 155 | 7.121 | 13.378 | 19.889 | 30.323 | 33.675 | 36.861 | 37.039 | 34.986 | 32.919 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 23.726 | 358 | 309 | 769 | 5.064 | 4.814 | 273 | 292 | 361 | 318 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Perfmed S.r.l.